Education
About Us
Working with TipRanks
Follow Us
Genflow Biosciences Plc (GB:GENF)
:GENF
GENF Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.96 - $3.41
Previous CloseN/A
Volume13.76K
Average Volume (3M)3.47M
Market Cap
N/A
Enterprise Value$7.13M
Total Cash (Recent Filing)£2.95M
Total Debt (Recent Filing)£0.00
Price to Earnings (P/E)―
Beta0.47
Next Earnings
Sep 26, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding391,047,940
10 Day Avg. Volume5,816,312
30 Day Avg. Volume3,465,459
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-12.30
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
Genflow Biosciences Plc News
PremiumCompany Announcements
Genflow Biosciences Launches Innovative Ophthalmology Gene Therapy Program
PremiumCompany Announcements
Genflow Biosciences Announces Change in Voting Rights
PremiumCompany Announcements
Genflow CEO Increases Stake, Signaling Confidence in Biotech Innovations
PremiumCompany Announcements
Genflow Biosciences Advances SIRT6 Variant Patent in Europe
PremiumCompany Announcements
Genflow Biosciences Voting Rights Change Announced
PremiumCompany Announcements
Genflow Biosciences: A Year of Breakthroughs in Anti-Aging TherapeuticsPremiumCompany Announcements
Genflow Biosciences Gains €4 Million for MASH Therapy---
Options Prices
Currently, No data available
---
Ownership Overview
32.39% Insiders
―
Mutual Funds
― Other Institutional Investors
67.61% Public Companies and
Individual Investors
GENF FAQ
What was Genflow Biosciences Plc’s price range in the past 12 months?
Genflow Biosciences Plc lowest share price was $0.95 and its highest was $3.41 in the past 12 months.
What is Genflow Biosciences Plc’s market cap?
Currently, no data Available
When is Genflow Biosciences Plc’s upcoming earnings report date?
Genflow Biosciences Plc’s upcoming earnings report date is Sep 26, 2025 which is in 150 days.
How were Genflow Biosciences Plc’s earnings last quarter?
Currently, no data Available
Is Genflow Biosciences Plc overvalued?
According to Wall Street analysts Genflow Biosciences Plc’s price is currently Overvalued.
Does Genflow Biosciences Plc pay dividends?
Genflow Biosciences Plc does not currently pay dividends.
What is Genflow Biosciences Plc’s EPS estimate?
Genflow Biosciences Plc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Genflow Biosciences Plc have?
Genflow Biosciences Plc has 391,047,940 shares outstanding.
What happened to Genflow Biosciences Plc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Genflow Biosciences Plc?
Currently, no hedge funds are holding shares in GB:GENF
---
Company Description
Genflow Biosciences Plc
Genflow Biosciences plc operates as a biotechnology company that focuses on developing biological interventions aimed at tackling the effects of ageing, slowing or halting the ageing process, and reducing the incidence of age-related diseases with increase in health span. Its lead compound is GF-1002, a suspension of an adeno-associated viral vector-based gene therapy for intravenous infusion. The company is also developing GF-3001, a topical delivery of SIRT6 to the skin; and GF-4001, a non-human pipeline anti-aging for veterinary use. The company was incorporated in 2021 and is headquartered in London, the United Kingdom.
---
Technical Analysis
HUTCHMED (China)
―
IXICO plc
―
Oxford BioDynamics
―
RWS Holdings
―
Scancell Holdings
―
---